Greenwood Gearhart Inc.在Merck的股份增加了8.2%,尽管该公司缺少EPS的估计。 Greenwood Gearhart Inc. increased its stake in Merck by 8.2%, despite the company missing EPS estimates.

Greenwood Gearhart Inc.在第四季度将Merck & Co. Inc.的股份增加8.2%,获得113 650股。 Greenwood Gearhart Inc. boosted its holdings in Merck & Co., Inc. by 8.2% in the fourth quarter, acquiring 113,650 shares. Merck报告说,收入增加了6.8%,达到156.2亿美元,但错过了EPS的估计,为17.2美元。 Merck reported a 6.8% rise in revenue to $15.62 billion but missed EPS estimates with $1.72. 股票的评级是“机动购买”,目标价格是115.50美元。 The stock has a "Moderate Buy" rating and a target price of $115.50. Merck是一家医疗保健公司,提供处方药、疫苗和消费者护理产品。 Merck, a health care company, offers products in prescription medicines, vaccines, and consumer care.